Ran Zhu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Positron Emission Tomography

Gold Nanoparticles

Top Venues

Molecular pharmaceutics

Journal of nanobiotechnology

Bioconjugate chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Shuo Jin, Jintao Huang, Yi Dong, Di Hu, Jing Sun, Zhihao Li, Bin-Yan Zhong, Zhiyong Liu, Ran Zhu, Guanglin Wang
Ultrastable PLGA-Coated 177 Lu-Microspheres for Radioembolization Therapy of Hepatocellular Carcinoma. Molecular pharmaceutics (2024)
Shuo Jin, Jintao Huang, Yi Dong, Di Hu, Jing Sun, Zhihao Li, Bin-Yan Zhong, Zhiyong Liu, Ran Zhu, Guanglin Wang
Ultrastable PLGA-Coated 177 Lu-Microspheres for Radioembolization Therapy of Hepatocellular Carcinoma. Molecular pharmaceutics 21 (7) (2024)
Xiumin Shi, Teng Liu, Pei Pei, Wenhao Shen, Lin Hu, Ran Zhu, Feng Wang, Chunying Chen, Kai Yang
Radionuclide-Labeled Antisilencing Function 1a Inhibitory Peptides for Tumor Identification and Individualized Therapy. ACS nano 18 (12) (2024)
Xiumin Shi, Teng Liu, Pei Pei, Wenhao Shen, Lin Hu, Ran Zhu, Feng Wang, Chunying Chen, Kai Yang
Radionuclide-Labeled Antisilencing Function 1a Inhibitory Peptides for Tumor Identification and Individualized Therapy. ACS nano 18 (12) (2024)
Xiumin Shi, Teng Liu, Pei Pei, Wenhao Shen, Lin Hu, Ran Zhu, Feng Wang, Chunying Chen, Kai Yang
Radionuclide-Labeled Antisilencing Function 1a Inhibitory Peptides for Tumor Identification and Individualized Therapy. ACS nano (2024)
Xiumin Shi, Qing Li, Chuan Zhang, Hailong Pei, Guanglin Wang, Hui Zhou, Longfei Fan, Kai Yang, Bo Jiang, Feng Wang, Ran Zhu
Semiconducting polymer nano-radiopharmaceutical for combined radio-photothermal therapy of pancreatic tumor. Journal of nanobiotechnology 19 (1) (2021)
Xiumin Shi, Qing Li, Lulu Zhang, Masayuki Hanyu, Lin Xie, Kuan Hu, Kotaro Nagatsu, Chuan Zhang, Zhengcan Wu, Feng Wang, Ming-Rong Zhang, Kai Yang, Ran Zhu
211At-Labeled Polymer Nanoparticles for Targeted Radionuclide Therapy of Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR)-Overexpressed Cancer. Bioconjugate chemistry 32 (8) (2021)